Salience Level for Visual Attention
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how the brain decides where to look when viewing a scene, such as finding Waldo in a "Where's Waldo" game. Researchers aim to understand how certain brain regions map out important areas based on features like color or motion, known as Feature Dimension Maps. Participants will watch images on a screen while researchers track their gaze to learn how the brain processes these visual cues. This research could enhance understanding of how the visual system functions in healthy individuals. Candidates with normal vision, with or without glasses or contacts, might be a good fit. As an unphased study, this trial offers a unique opportunity to contribute to foundational research on visual processing.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this method is safe for participants?
Previous studies have shown that the brain uses 'feature dimension maps' to focus on important visual details, such as color or motion. This mechanism helps guide attention in scenes with many distractions. The treatment in this trial involves observing different visual patterns to understand how these brain areas function.
There are no specific safety concerns with this treatment, as it primarily involves watching visual patterns and tracking eye movements. To date, no negative effects have been reported from this type of research. Participants will simply view images on a screen, which is a normal and safe activity.12345Why are researchers excited about this trial?
Researchers are excited about the trial examining Feature Dimension Maps for visual attention because it explores how manipulating visual features like color and motion can enhance attention. Unlike standard methods that may not focus on feature contrast, this approach aims to make certain stimuli more noticeable by adjusting their visual properties. This could lead to a deeper understanding of how visual attention can be optimized, potentially informing new ways to help individuals with attention-related challenges.
What evidence suggests that this trial's treatments could be effective for visual attention?
Research has shown that certain areas in the brain help focus on visual stimuli by acting as 'feature maps.' These maps can identify important spots based on attributes like color or movement. For example, if something bright red appears against a dull background, the brain's color map might highlight it as significant. This trial will explore how manipulating the salience of features, such as color or motion direction, affects visual attention. Studies suggest that these feature maps guide attention by making standout features more noticeable, thus aiding in locating specific targets.56789
Who Is on the Research Team?
Tommy Sprague
Principal Investigator
University of California, Santa Barbara
Are You a Good Fit for This Trial?
This trial is for individuals aged 18 to 55 with normal or corrected-to-normal vision. It's designed to explore how people focus their attention on different parts of a visual scene, like finding Waldo in a busy picture.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Experimental Manipulation
Participants view stimuli with varying feature salience based on color, motion, or luminance contrast. Eye-tracking data is collected to analyze gaze positions.
Follow-up
Participants are monitored for any additional data collection or analysis post-experiment.
What Are the Treatments Tested in This Trial?
Interventions
- Feature Dimension Maps
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Santa Barbara
Lead Sponsor
National Eye Institute (NEI)
Collaborator